持续血液滤过治疗心源性休克临床观察  

Clinical Study of Continous Hemofiltration in treatment of cardiogenic shock

作　　者：宁波[1] 张赤兵[1] 马宇洁[1] 李一粟[1] 马建珍[1] 

机构地区：[1]空军总医院ICU,北京100142

出　　处：《空军总医院学报》2010年第1期38-39,共2页Journal of General Hospital of Air Force,PLA

摘　　要：目的总结我院血液滤过辅助治疗心源性休克经验。方法回顾性分析了2005年12月~2009年12月我院抢救的心源性休克患者21例,经药物治疗无效后,使用持续血液滤过方法辅助治疗。结果确诊心源性休克后12 h内血液滤过治疗患者7 d生存率为81.8%,12 h后开始血液滤过治疗患者7 d生存率为40.0%,差异十分显著（P〈0.01）。结论早期血液滤过治疗可以有效提高心源性休克患者生存率。Objective To summarize the clinical value of continuous hemofiltration for cardiogenic shock patients.Methods From Dec.2005 to Dec 2009,continuous hemofiltration therapy was applied to 21 cardiogenic shock patients who were not effective with conventional therapy.Results 11 patients with continuous hemofiltration therapy within 12 h after cardiogenic shock,the 7-day survival rate was 81.8%,10 patients with continuous hemofiltration therapy over 12h after cardiogenic shock,the 7-day survival rate was 40.0%,there was significant difference（P0.01）.Conclusion Continuous hemofiltration therapy can decrease the mobility of patients with cardiogenic shock.

关 键 词：血液滤过 休克 心源性/治疗 

分 类 号：R542.22[医药卫生—心血管疾病]